These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 38261245)

  • 1. Post-infection irritable bowel syndrome following Coronavirus disease-19: A systematic review and meta-analysis.
    Mathur A; Shams U; Mishra P; Sahu S; Goenka MK; Ghoshal U; Ghoshal UC
    Indian J Gastroenterol; 2024 Jun; 43(3):557-566. PubMed ID: 38261245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-infection functional gastrointestinal disorders following coronavirus disease-19: a prospective follow-up cohort study.
    Zhang D; Chen C; Xie Y; Zeng F; Chen S; Chen R; Zhang X; Huang S; Li D; Bai F
    BMC Infect Dis; 2023 Jun; 23(1):422. PubMed ID: 37344782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meta-analysis: Post-COVID-19 functional dyspepsia and irritable bowel syndrome.
    Marasco G; Maida M; Cremon C; Barbaro MR; Stanghellini V; Barbara G
    Aliment Pharmacol Ther; 2023 Jul; 58(1):6-15. PubMed ID: 37038318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-infection functional gastrointestinal disorders following coronavirus disease-19: A case-control study.
    Ghoshal UC; Ghoshal U; Rahman MM; Mathur A; Rai S; Akhter M; Mostafa T; Islam MS; Haque SA; Pandey A; Kibria MG; Ahmed F
    J Gastroenterol Hepatol; 2022 Mar; 37(3):489-498. PubMed ID: 34672022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prevalence of combination of functional dyspepsia and irritable bowel syndrome: a meta-analysis of studies using the Rome III-IV Criteria].
    Andreev DN; Bordin DS; Vyuchnova ES; Lebedeva EG; Dicheva DT; Umyarova RM; Maev IV
    Ter Arkh; 2022 Oct; 94(9):1099-1108. PubMed ID: 36286762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is there an association between
    Ng QX; Foo NX; Loke W; Koh YQ; Seah VJM; Soh AYS; Yeo WS
    World J Gastroenterol; 2019 Oct; 25(37):5702-5710. PubMed ID: 31602169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impacts of the COVID-19 pandemic on functional dyspepsia and irritable bowel syndrome: A population-based survey.
    Oshima T; Siah KTH; Yoshimoto T; Miura K; Tomita T; Fukui H; Miwa H
    J Gastroenterol Hepatol; 2021 Jul; 36(7):1820-1827. PubMed ID: 33197076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persisting gastrointestinal symptoms and post-infectious irritable bowel syndrome following SARS-CoV-2 infection: results from the Arizona CoVHORT.
    Austhof E; Bell ML; Riddle MS; Catalfamo C; McFadden C; Cooper K; Scallan Walter E; Jacobs E; Pogreba-Brown K
    Epidemiol Infect; 2022 Jul; 150():e136. PubMed ID: 35801302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tegaserod for the treatment of irritable bowel syndrome.
    Evans BW; Clark WK; Moore DJ; Whorwell PJ
    Cochrane Database Syst Rev; 2004; (1):CD003960. PubMed ID: 14974049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Global prevalence of irritable bowel syndrome according to Rome III or IV criteria: a systematic review and meta-analysis.
    Oka P; Parr H; Barberio B; Black CJ; Savarino EV; Ford AC
    Lancet Gastroenterol Hepatol; 2020 Oct; 5(10):908-917. PubMed ID: 32702295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The incidence and predisposing factors for irritable bowel syndrome following COVID-19: a systematic review and meta-analysis.
    Wang YN; Zhou LY; Huang YH; Jiang M; Dai C
    Eur J Gastroenterol Hepatol; 2024 Feb; 36(2):168-176. PubMed ID: 38047738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-Term Gastrointestinal Consequences are Frequent Following Sporadic Acute Infectious Diarrhea in a Tropical Country: A Prospective Cohort Study.
    Rahman MM; Ghoshal UC; Sultana S; Kibria MG; Sultana N; Khan ZA; Ahmed F; Hasan M; Ahmed T; Sarker SA
    Am J Gastroenterol; 2018 Sep; 113(9):1363-1375. PubMed ID: 30171215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-COVID-19 and Irritable Bowel Syndrome: A Literature Review.
    Paramythiotis D; Karlafti E; Didagelos M; Fafouti M; Veroplidou K; Protopapas AA; Kaiafa G; Netta S; Michalopoulos A; Savopoulos C
    Medicina (Kaunas); 2023 Nov; 59(11):. PubMed ID: 38004010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tegaserod for the treatment of irritable bowel syndrome and chronic constipation.
    Evans BW; Clark WK; Moore DJ; Whorwell PJ
    Cochrane Database Syst Rev; 2007 Oct; (4):CD003960. PubMed ID: 17943807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastrointestinal manifestations of long COVID: A systematic review and meta-analysis.
    Choudhury A; Tariq R; Jena A; Vesely EK; Singh S; Khanna S; Sharma V
    Therap Adv Gastroenterol; 2022; 15():17562848221118403. PubMed ID: 36004306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acupuncture and moxibustion for irritable bowel syndrome: An umbrella systematic review.
    Ma YY; Hao Z; Chen ZY; Shen YX; Liu HR; Wu HG; Bao CH
    J Integr Med; 2024 Jan; 22(1):22-31. PubMed ID: 38199885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Prevalence of Irritable Bowel Syndrome after Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Their Association: A Systematic Review and Meta-Analysis of Observational Studies.
    Wang Z; Peng Y; Chen M; Peng L; Huang Y; Lin W
    J Clin Med; 2023 Feb; 12(5):. PubMed ID: 36902651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in gastrointestinal symptoms according to gender in Rome II positive IBS and dyspepsia in a Latin American population.
    Schmulson M; Adeyemo M; Gutiérrez-Reyes G; Charúa-Guindic L; Farfán-Labonne B; Ostrosky-Solis F; Díaz-Anzaldúa A; Medina L; Chang L
    Am J Gastroenterol; 2010 Apr; 105(4):925-32. PubMed ID: 20179693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence, Risk Factors, and Outcomes of Irritable Bowel Syndrome After Infectious Enteritis: A Systematic Review and Meta-analysis.
    Klem F; Wadhwa A; Prokop LJ; Sundt WJ; Farrugia G; Camilleri M; Singh S; Grover M
    Gastroenterology; 2017 Apr; 152(5):1042-1054.e1. PubMed ID: 28069350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.